Study on histopathology of the china-made drug-eluting stent with sirolimus-heparin placed in the peripheral artery:an experimental study in dogs
Bo FENG,Xu DAI,Qiang SHI,Yong-hui XIA,Song-nian LIANG,Ying-ying HUANG,Min QI,Ke XU
2008-01-01
Abstract:Objective: To evaluate the histopathological characteristics of the china-made sirolimus-heparin eluting stent placed in the dog's peripheral arteries. Methods: A total of 28 stents (12 sirolimus-heparin eluting stents, 8 sirolimus stents and 8 bare stents) were implanted into peripheral arteries of 14 dogs. Seven dogs were killed after 30 days, the others were killed after 60 days. The stented-arteries of 14 dogs were dissected and observed focusing on the thrombosis, hemorrhage, necrosis and inflammation, and the neointimal thickness, neoinitial area, intimal endothelialization score, initial fibrin content, initial smooth muscle cell content were calculatedand statistically analyzed. Results: At 30 days, the sirolimus-heparin stent and sirolimus stent had no initial hyperplasia, but small quantity of smooth muscle cells, large quantity of fibrins and a little of endothelial cells. The bare stent had a large quantity of smooth muscle cells, a little fibrins and a little of endothelial cells without initial hyperplasia. At 60 days, the sirolimus-heparin stent had no initial hyperplasia, small quantity of smooth muscle cells, large quantity of fibrins, a little endothelial cells. The sirolimus stent had no initial hyperplasia, while small quantity of smooth muscle cells, large quantity of fibrins, a little of endothelial cells and thrombosis were observed in 2 stents. The bare stent had initial hyperplasia, large quantity of smooth muscle cells and endothelial cells, and a little of fibrins. At 30 days, there were statistic significant differences in initial 1 fibrin content and initial smooth muscle cell content among sirolimus-heparin stent, sirolimus stent and bare stent (P<0.01). At 60 days, significant differences were found among sirolimus-heparin stent, sirolimus stent and bare stent in the neointimal thickness, neointimal area, initial endothelialization score, initial fibrin content and initial smooth muscle cell content (P<0.01). Conclusion: The china-made peripheral arterial sirolimus-heparin eluting stent may inhibit initial hyperplasia and had the ability of anticoagulation.